These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29537443)

  • 21. Tavaborole in Difficult-to-Treat Onychomycosis Cases: A Post-hoc Assessment of Phase III Subjects.
    Aly R; Gupta AK; Winter T; Zane LT; Vlahovic T
    J Drugs Dermatol; 2017 Oct; 16(10):1016-1021. PubMed ID: 29036255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
    Lipner SR; Scher RK
    Expert Rev Clin Pharmacol; 2015; 8(6):719-31. PubMed ID: 26325488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical Tavaborole in the Treatment of Onychomycosis Complicated by Dermatophytoma: A Post-hoc Assessment of Phase II Subjects.
    Aly R; Winter T; Hall S; Vlahovic T
    J Drugs Dermatol; 2018 Mar; 17(3):347-354. PubMed ID: 29537453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifungal agents for onychomycosis: new treatment strategies to improve safety.
    Zane LT; Chanda S; Coronado D; Del Rosso J
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical therapy for toenail onychomycosis: an evidence-based review.
    Gupta AK; Daigle D; Foley KA
    Am J Clin Dermatol; 2014 Dec; 15(6):489-502. PubMed ID: 25257931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of onychomycosis using a 1064-nm diode laser with or without topical antifungal therapy: a single-center, retrospective analysis in 56 patients.
    Weber GC; Firouzi P; Baran AM; Bölke E; Schrumpf H; Buhren BA; Homey B; Gerber PA
    Eur J Med Res; 2018 Oct; 23(1):53. PubMed ID: 30355363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Onychomycosis--treatment, relapse and re-infection.
    Hull PR
    Dermatology; 1997; 194 Suppl 1():7-9. PubMed ID: 9154393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efinaconazole: a new topical treatment for onychomycosis.
    Gupta AK; Simpson FC
    Skin Therapy Lett; 2014; 19(1):1-4. PubMed ID: 24570290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical antifungal treatment prevents recurrence of toenail onychomycosis following cure.
    Shemer A; Gupta AK; Kamshov A; Babaev M; Farhi R; Daniel CR; Foley KA
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28856784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of Pharmacists in Topical Therapy for Onychomycosis in the Home-care Setting].
    Yamaura K; Hayashi N; Imazu Y; Yoneta Y; Uchida E; Suzuki J
    Yakugaku Zasshi; 2018; 138(5):615-619. PubMed ID: 29710003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory monitoring during treatment of onychomycosis in pediatric patients: A survey of provider perspectives and practices.
    Brockman R; Funk T
    Pediatr Dermatol; 2021 Jul; 38(4):764-767. PubMed ID: 34089199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
    Gupta AK; Pillai R
    J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Follow-up of Onychomycosis Patients Treated With Efinaconazole.
    Pollak RA; Ilie C
    J Drugs Dermatol; 2017 Dec; 16(12):1269-1273. PubMed ID: 29240863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic potential of TDT 067 (terbinafine in Transfersome): a carrier-based dosage form of terbinafine for onychomycosis.
    Sigurgeirsson B; Ghannoum M
    Expert Opin Investig Drugs; 2012 Oct; 21(10):1549-62. PubMed ID: 22876754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of Confirmatory Testing Before Treatment of Onychomycosis.
    Mikailov A; Cohen J; Joyce C; Mostaghimi A
    JAMA Dermatol; 2016 Mar; 152(3):276-81. PubMed ID: 26716567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of fractional carbon dioxide (CO
    Shi J; Li J; Huang H; Permatasari F; Liu J; Xu Y; Wu D; Zhou BR; Luo D
    J Cosmet Laser Ther; 2017 Oct; 19(6):353-359. PubMed ID: 28557542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Report of a case of a dermatophytoma successfully treated with topical efinaconazole 10% solution.
    Cantrell W; Canavan T; Elewski B
    J Drugs Dermatol; 2015 May; 14(5):524-6. PubMed ID: 25942674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
    Kircik LH
    J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efinaconazole topical solution, 10%: the benefits of treating onychomycosis early.
    Rich P
    J Drugs Dermatol; 2015 Jan; 14(1):58-62. PubMed ID: 25607909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.